Unconjugated anti-bacteria primary antibodies are native immunoglobulin molecules specifically raised against bacterial antigens, available without chemical modifications or fluorescent or enzymatic labels. These versatile reagents serve as foundational tools for immunological detection, functional assays, and therapeutic development targeting bacterial pathogens.

Core Properties and Production

Production Methods

Unconjugated anti-bacteria primary antibodies are generated using well-established immunization and selection strategies:

• Polyclonal antibodies: Produced by immunizing animals such as rabbits, goats, or sheep with heat-inactivated whole bacterial cells, purified lipopolysaccharides (LPS), or recombinant surface proteins. Affinity purification against native antigens ensures high-titer specificity.
• Monoclonal antibodies: Derived from hybridoma fusion or phage display technologies, enabling single-epitope recognition with high specificity, consistent performance, and unlimited supply.

Purification Standards

To ensure high quality and suitability for research and biological applications, these antibodies are typically processed under stringent purification criteria:

• Protein G or Protein A affinity chromatography achieving >95% purity.
• Cross-adsorption against related bacterial strains to minimize cross-reactivity.
• Preservative-free formulations suitable for sensitive cell culture systems.
• Endotoxin levels maintained below 1 EU/μg for in vivo compatibility.